GSK’s leadership in respiratory medicine goes beyond science—uniting research, collaboration, and care to transform outcomes ...
Tasmanian scientists are leading the national fight against life-threatening pollen storms, in a $8.9 million research ...
Away from COP30's official talks, African activists in Belem, Brazil, joined the People's Summit to expose climate injustices and push for reparations. DW spoke to some of the people leading this ...
To keep up with COPD research and care developments, the 2026 Global Initiative for Chronic Obstructive Lung Disease report ...
Away from COP30's official talks, African activists in Belem, Brazil, joined the People's Summit to expose climate injustices ...
An estimated 47% of homes already have mold or dampness, leaving their residents exposed to mold spores and associated ...
Tennessee is proving that strategic investments in nature deliver measurable gains in both human health and economic ...
In the late 1990s, scientists and physicians increasingly reported a little-known health threat: peanut allergies. Estimates ...
The European Commission (EC) has granted a line extension in the European Union (EU) for Celltrion's Omlyclotm (omalizumab), Europe's first and only omalizumab biosimilar, for the 300 mg/2ml prefilled ...